Search results for "rex"

showing 10 items of 701 documents

Prediction of leukocyte counts during paediatric acute lymphoblastic leukaemia maintenance therapy

2019

Maintenance chemotherapy with oral 6-mercaptopurine and methotrexate remains a cornerstone of modern therapy for acute lymphoblastic leukaemia. The dosage and intensity of therapy are based on surrogate markers such as peripheral blood leukocyte and neutrophil counts. Dosage based leukocyte count predictions could provide support for dosage decisions clinicians face trying to find and maintain an appropriate dosage for the individual patient. We present two Bayesian nonlinear state space models for predicting patient leukocyte counts during the maintenance therapy. The models simplify some aspects of previously proposed models but allow for some extra flexibility. Our second model is an ext…

MaleTime seriesAdolescentaikasarjatNeutrophilsDatasets as Topiclcsh:MedicinebiomarkkeritModels BiologicalArticleMaintenance ChemotherapyPaediatric cancerLeukocyte CountSyöpätaudit - CancersAntineoplastic Combined Chemotherapy ProtocolsLeukocytesHumansDrug Dosage CalculationsChildlcsh:Sciencetilastolliset mallitStochastic modellingstokastiset prosessitStochastic ProcessesvalkosolutMercaptopurinebayesilainen menetelmäStatisticslcsh:RInfantennusteetBayes TheoremPrecursor Cell Lymphoblastic Leukemia-LymphomaApplied mathematicsMethotrexateChild Preschoollääkehoitoakuutti lymfaattinen leukemiasyöpätauditFemalelcsh:Q
researchProduct

The use of corticosteroids in home palliative care

2001

Evidence for the effectiveness of corticosteroids in palliative care is anecdotal, and more information is required. From January to December 1999 a total of 376 consecutive patients admitted to a home palliative care program were longitudinally surveyed. Patients who started a corticosteroid treatment after admission on the basis of common indications prescribed by their home care physicians were selected. Fifty patients were enrolled in the study. Dexametha-sone, in doses ranging from 4 to 16 mg, was the drug of choice. Corticosteroids were found to be effective in anorexia, weakness, headache, and nausea and vomiting. The reduction of symptom intensity was achieved in less than 3 days on…

MaleWeaknessPediatricsmedicine.medical_specialtyPalliative careNauseaLongitudinal epedemiological studyAnorexiaHome palliative careDexamethasoneStatistics NonparametricmedicineHumansCorticosteroidLongitudinal StudiesAdverse effectIntensive care medicineGlucocorticoidsNursing (all)2901 Nursing (miscellaneous)AgedAged 80 and overbusiness.industryPalliative CareTherapeutic effectMiddle Agedmedicine.diseaseHome Care ServicesBowel obstructionItalyOncologyVomitingFemalemedicine.symptombusiness
researchProduct

Hypothalamic eIF2 alpha signaling regulates food intake

2014

International audience; The reversible phosphorylation of the a subunit of eukaryotic initiation factor 2 (eIF2 alpha) is a highly conserved signal implicated in the cellular adaptation to numerous stresses such as the one caused by amino acid limitation. In response to dietary amino acid deficiency, the brain-specific activation of the eIF2 alpha kinase GCN2 leads to food intake inhibition. We report here that GCN2 is rapidly activated in the mediobasal hypothalamus (MBH) after consumption of a leucine-deficient diet. Furthermore, knockdown of GCN2 in this particular area shows that MBH GCN2 activity controls the onset of the aversive response. Importantly, pharmacological experiments demo…

Male[ SDV.AEN ] Life Sciences [q-bio]/Food and NutritionEukaryotic Initiation Factor-2neuronsEatingMicepiriform cortex0302 clinical medicineGene Knockdown Techniquesarcuate nucleusamino-acid deficiency;arcuate nucleus;translational control;energy homeostasis;piriform cortex;cancer cachexia;protein-intake;transfer-rna;mechanism;neuronsPhosphorylationlcsh:QH301-705.52. Zero hungerchemistry.chemical_classification0303 health sciencesGene knockdownalimentationtranslational controlamino-acid deficiencyEukaryotic Initiation Factor-2Amino acidtransfer-rnaGene Knockdown TechniquesAlimentation et NutritionPhosphorylation[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]Signal transductionmedicine.symptomSignal Transductioncancer cachexiamedicine.medical_specialtyCellular adaptationHypothalamusmechanismAnorexiaBiologyProtein Serine-Threonine KinasesGeneral Biochemistry Genetics and Molecular BiologyArticle03 medical and health sciencesLeucineInternal medicinemedicineFood and NutritionAnimalsenergy homeostasis030304 developmental biologyNeurosciencesArcuate Nucleus of Hypothalamusprotein-intakeMice Inbred C57BL[SDV.AEN] Life Sciences [q-bio]/Food and NutritionEndocrinologychemistrylcsh:Biology (General)Neurons and Cognition[SDV.AEN]Life Sciences [q-bio]/Food and Nutrition030217 neurology & neurosurgery
researchProduct

Etanercept treatment for extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis, or psoriatic arthritis : 6-year efficac…

2019

Background To describe the 6-year safety and efficacy of etanercept (ETN) in children with extended oligoarticular juvenile idiopathic arthritis (eoJIA), enthesitis-related arthritis (ERA), and psoriatic arthritis (PsA) Methods Patients who completed the 2-year, open-label, phase III CLinical Study In Pediatric Patients of Etanercept for Treatment of ERA, PsA, and Extended Oligoarthritis (CLIPPER) were allowed to enroll in its 8-year long-term extension (CLIPPER2). Children received ETN at a once-weekly dose of 0.8 mg/kg, up to a maximum dose of 50 mg/week. Efficacy assessments included the JIA core set of outcomes, the JIA American College of Rheumatology response criteria (JIA-ACR), and t…

Malelcsh:Diseases of the musculoskeletal systemArthritisCHILDRENCATEGORIESDISEASE-ACTIVITYEtanerceptEtanerceptEnthesitis-related arthritis (ERA)Juvenile Arthritis Disease Activity ScoreDOUBLE-BLINDINITIATIONNECROSIS-FACTORDEFINING CRITERIAMedicine and Health SciencesMedicineChildNon-U.S. Gov'tClinical trial; Efficacy; Enthesitis-related arthritis; Enthesitis-related arthritis (ERA); Etanercept; Extended oligoarticular juvenile idiopathic arthritis (eoJIA); Juvenile idiopathic arthritis; Psoriatic arthritis (PsA); SafetyOligoarthritisResearch Support Non-U.S. Gov'tMETHOTREXATEClinical trialTreatment OutcomeAntirheumatic AgentsChild PreschoolFemaleSafetymedicine.drugResearch Articlemedicine.medical_specialtyAdolescentEfficacyEnthesitis-related arthritisResearch SupportPsoriatic arthritisPsoriatic arthritis (PsA)Internal medicineAdalimumabJournal ArticleHumansetanercept ; juvenile idiopathic arthritis ; enthesitis-related arthritis ; extended oligoarticular juvenile idiopathic arthritis (eoJIA) ; enthesitis-related arthritis (ERA) ; psoriatic arthritis (PsA) ; efficacy ; safety ; clinical trialPEDIATRIC-PATIENTSbusiness.industryJuvenile idiopathic arthritismedicine.diseaseRheumatologyArthritis JuvenileOligoarticular Juvenile Idiopathic Arthritislcsh:RC925-935Extended oligoarticular juvenile idiopathic arthritis (eoJIA)businessADALIMUMAB
researchProduct

Influence of Stress in the Onset of Eating Disorders: Data From a Two-Stage Epidemiologic Controlled Study

2006

Background We explore the role of stress in the onset of eating disorders (EDs) in a community sample of adolescents, the mediating role of psychiatric comorbidity and the quantitative evolution of stress in the year preceding the onset of an ED. Methods The Life Events and Difficulties Schedule interview was applied to a sample with 32 cases and 32 controls selected from a two-phase epidemiologic study among a representative population of adolescents, followed by a decay model to assess acute and chronic stress in the year preceding the onset of ED. Psychiatric comorbidity was assessed using the SCAN interview. Results Cases (46.9%) and 9.4% of controls were found to have associated psychi…

Malemedicine.medical_specialtyAdolescentPersonality InventoryPopulationComorbiditySampling StudiesFeeding and Eating DisordersLife Change Eventssymbols.namesakeSurveys and QuestionnairesInternal medicineHumansMedicineChronic stressChildPsychiatryeducationApplied PsychologyFisher's exact testPsychiatric Status Rating Scaleseducation.field_of_studybusiness.industryData CollectionMental DisordersLife Events and Difficulties ScheduleCase-control studymedicine.diseaseComorbidityPsychiatry and Mental healthEating disordersSpainAnorexia nervosa (differential diagnoses)Case-Control StudiesChronic DiseasesymbolsFemalebusinessStress PsychologicalPsychosomatic Medicine
researchProduct

Senile anorexia in acute-ward and rehabilitations settings.

2008

The most common pathological change in eating behaviour among older persons is anorexia, which accounts for a large percent of undernutrition in older adults. The main research aims are to determine, in a sample of acute and rehabilitation elderly subjects, the prevalence of anorexia of aging and the causes most impacting on senile anorexia.Methods: four different Units cooperated to this research study. Patients were recruited from geriatric acute and rehabilitation wards in Italy. Each Research Unit, for the estimation of the prevalence of anorexia in elderly subjects evaluated all the patients aged over 65 recruited from April 2006 to June 2007. Nutritional status, depression, social, fu…

Malemedicine.medical_specialtyAgingmedicine.medical_treatmentHealth StatusMedicine (miscellaneous)Nutritional StatusAnorexiaSwallowingQuality of lifemedicinePrevalenceHumansGeriatric AssessmentDepression (differential diagnoses)AgedAged 80 and overNutrition and DieteticsRehabilitationbusiness.industrydigestive oral and skin physiologyAnthropometrymedicine.diseaseComorbidityAnorexiaMalnutritionC-Reactive ProteinNutrition AssessmentCase-Control StudiesPhysical therapyQuality of LifeFemaleGeriatrics and Gerontologymedicine.symptombusinessThe journal of nutrition, healthaging
researchProduct

Gene Transcription Alterations Associated with Decrease of Ethanol Intake Induced by Naltrexone in the Brain of Wistar Rats

2006

Preclinical and clinical studies suggest that the administration of the opioid antagonist naltrexone decreases the intake of ethanol. However, the neuroplastic adaptations in the brain associated to reduction of ethanol consumption remains to be elucidated. The aim of the study was to identify gene transcription alterations underlying the attenuation of voluntary ethanol intake by administration of naltrexone in rats. Increasing doses of naltrexone (0.7 mg/kg, 4 days and 1.4 mg/kg/day, 4 days) to rats with acquired high preferring ethanol consumption (>3.5 g of ethanol/kg/day) decreased voluntary ethanol intake (50%). Voluntary ethanol consumption altered mu-opioid receptor function in the …

Malemedicine.medical_specialtyAlcohol DrinkingTranscription Geneticmedicine.drug_classNarcotic AntagonistsNucleus accumbensPharmacologyNaltrexoneInternal medicineImage Processing Computer-AssistedmedicineAnimalsRats WistarOpioid peptideIn Situ HybridizationBrain ChemistryPharmacologyEthanolTyrosine hydroxylaseChemistryOlfactory tubercleCentral Nervous System DepressantsEnkephalin Ala(2)-MePhe(4)-Gly(5)-NaltrexoneRatsAnalgesics OpioidVentral tegmental areaPsychiatry and Mental healthmedicine.anatomical_structureEndocrinologynervous systemGuanosine 5'-O-(3-Thiotriphosphate)HypothalamusAutoradiographyOpioid antagonistmedicine.drugNeuropsychopharmacology
researchProduct

The Novel μ-Opioid Receptor Antagonist GSK1521498 Decreases Both Alcohol Seeking and Drinking: Evidence from a New Preclinical Model of Alcohol Seeki…

2015

Distinct environmental and conditioned stimuli influencing ethanol-associated appetitive and consummatory behaviors may jointly contribute to alcohol addiction. To develop an effective translational animal model that illuminates this interaction, daily seeking responses, maintained by alcohol-associated conditioned stimuli (CSs), need to be dissociated from alcohol drinking behavior. For this, we established a procedure whereby alcohol seeking maintained by alcohol-associated CSs is followed by a period during which rats have the opportunity to drink alcohol. This cue-controlled alcohol-seeking procedure was used to compare the effects of naltrexone and GSK1521498, a novel selective μ-opioi…

Malemedicine.medical_specialtyAlcohol Drinkingmedia_common.quotation_subjectNarcotic AntagonistsDrug-Seeking BehaviorDrug Evaluation PreclinicalReceptors Opioid muPoison controlAlcoholContext (language use)Choice BehaviorNaltrexonechemistry.chemical_compoundSpecies SpecificitymedicineAnimalsPsychiatrymedia_commonPharmacologyDose-Response Relationship DrugAddictionAbstinenceTriazolesNaltrexoneRatsPsychiatry and Mental healthDisease Models AnimalchemistryAlcohol DeterrentsAnesthesiaIndansCommentaryConditioning OperantBlood alcohol contentBlood Alcohol ContentCuesPsychologyAlcohol-Related DisordersReinforcement Psychologymedicine.drugAlcohol DeterrentsNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
researchProduct

Prediction of response to disease modifying antirheumatic drugs in rheumatoid arthritis.

2010

Abstract Aim To investigate potential predictors of response to conventional DMARDs in RA. Methods Study design – 6-month follow-up prospective study. Participants RA patients with active disease. Intervention and follow-up Introduction of one DMARD. Response to treatment evaluated at 6 months (ACR20 criteria). Analysis Potential predictors of response, patients’ demographics, disease activity, percentages of PBMC subsets expressing P-gp, serum IL-1β, IL-6, IL-8, IL-10, IL-12, TNF-α levels, were evaluated using univariate and multivariate logistic regression analysis. ROC curve analyses were performed in order to obtain thresholds allowing the prediction of response. Results Forty-two patie…

Malemedicine.medical_specialtyArthritisPainLogistic regressionSeverity of Illness IndexArthritis RheumatoidRheumatologyPredictive Value of TestsInternal medicinePositive predicative valueSeverity of illnessmedicineHumansProspective StudiesProspective cohort studybusiness.industryTumor Necrosis Factor-alphaReproducibility of ResultsMiddle Agedmedicine.diseaseLogistic ModelsMethotrexateTreatment OutcomeROC CurvePredictive value of testsRheumatoid arthritisAntirheumatic AgentsArea Under CurveImmunologyLeukocytes MononuclearBiomarker (medicine)FemaleJointsMultidrug Resistance-Associated ProteinsbusinessBiomarkersJoint bone spine
researchProduct

The role of temperament and character in the outcome of depressive mood in eating disorders.

2014

Abstract Objectives The aims were to see which temperament and character dimensions were associated with depression, mainly with its outcome at two-year follow up in eating disorders (EDs). Methods Participants (N = 151) were 44 Anorexia nervosa (AN), 55 Bulimia nervosa (BN) and 52 Eating disorders not otherwise specified (EDNOS) patients. The Beck Depression Inventory (BDI), State and Trait Anxiety Inventory (STAI), Rosenberg Self Esteem Questionnaire (RSE), Eating Disorder Inventory (EDI-2) and Temperament and Character Inventory (TCI) were administered. Results Depression at the beginning (t0) was severe in 22% of the cases. Harm Avoidance and Novelty Seeking had an effect on depressed m…

Malemedicine.medical_specialtyCharacterAnorexia Nervosalcsh:RC435-571media_common.quotation_subjectbehavioral disciplines and activitiesBody Mass IndexYoung Adultlcsh:Psychiatrymental disordersmedicineHumansProspective StudiesPsychiatryBulimia NervosaTemperamentmedia_commonDepressive DisorderBulimia nervosaNovelty seekingBeck Depression Inventorymedicine.diseaseEating Disorder InventoryPsychiatry and Mental healthClinical PsychologyEating disordersHarm avoidanceTemperament and Character InventoryTemperamentFemalePsychologyClinical psychologyComprehensive psychiatry
researchProduct